Virginia Regulatory Town Hall
Department of Health Professions
Board of Pharmacy

General Notice
Drug to be scheduled to conform to federal scheduling action
Date Posted: 11/15/2023
Expiration Date: 12/6/2023
Submitted to Registrar for publication: YES
No comment forum defined for this notice.

Notice of Public Hearing

Pursuant to subsection E of § 54.1-3443, the Board of Pharmacy is giving notice of a public hearing to consider placement of a chemical substance in Schedule IV of the Drug Control Act. The public hearing will be conducted at 9:05 a.m. on December 6, 2023. Instructions will be included in the agenda for the board meeting, also on December 6th. Public comment may also be submitted electronically or in writing prior to December 5th to Caroline Juran, Executive Director of the Board of Pharmacy to

Pursuant to article § 54.1-3443(E), the following drug will be removed from Schedule IV to conform with federal scheduling actions taken from February 4, 2023 to November 13, 2023:

  1. ZURZUVAE (zuranolone) 1-[2-[(3 R, 5 R, 8 R, 9 R, 10 S, 13 S, 14 S, 17 S)-3-hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1 H -cyclopenta[ a ]phenanthren-17-yl]-2-oxoethyl]pyrazole-4-carbonitrile).

Contact Information
Name / Title: Caroline Juran, RPh  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Henrico, 23233
Email Address:
Telephone: (804)367-4456    FAX: (804)527-4472    TDD: ()-